Souders Financial Advisors Has $762,000 Position in Danaher Corporation (NYSE:DHR)

Souders Financial Advisors lowered its position in Danaher Corporation (NYSE:DHR - Free Report) by 30.4% in the 1st quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 3,719 shares of the conglomerate's stock after selling 1,628 shares during the quarter. Souders Financial Advisors' holdings in Danaher were worth $762,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other institutional investors and hedge funds also recently made changes to their positions in the company. Heck Capital Advisors LLC acquired a new stake in Danaher during the 4th quarter valued at approximately $27,000. GHP Investment Advisors Inc. increased its position in Danaher by 396.0% during the 1st quarter. GHP Investment Advisors Inc. now owns 124 shares of the conglomerate's stock valued at $25,000 after purchasing an additional 99 shares during the period. Sierra Ocean LLC increased its position in Danaher by 116.9% during the 1st quarter. Sierra Ocean LLC now owns 141 shares of the conglomerate's stock valued at $29,000 after purchasing an additional 76 shares during the period. Hurley Capital LLC acquired a new stake in Danaher during the 4th quarter valued at approximately $34,000. Finally, Smallwood Wealth Investment Management LLC acquired a new stake in Danaher during the 1st quarter valued at approximately $31,000. Institutional investors and hedge funds own 79.05% of the company's stock.

Danaher Price Performance

Shares of Danaher stock opened at $189.98 on Friday. The company has a debt-to-equity ratio of 0.31, a current ratio of 1.43 and a quick ratio of 1.05. Danaher Corporation has a one year low of $171.00 and a one year high of $281.70. The stock has a market capitalization of $135.96 billion, a P/E ratio of 36.89, a price-to-earnings-growth ratio of 2.67 and a beta of 0.77. The business's 50 day simple moving average is $196.13 and its two-hundred day simple moving average is $205.03.

Danaher (NYSE:DHR - Get Free Report) last released its quarterly earnings results on Tuesday, April 22nd. The conglomerate reported $1.88 earnings per share for the quarter, beating the consensus estimate of $1.62 by $0.26. Danaher had a return on equity of 10.80% and a net margin of 15.81%. The company had revenue of $5.74 billion for the quarter, compared to analyst estimates of $5.58 billion. Analysts forecast that Danaher Corporation will post 7.63 EPS for the current year.

Danaher Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Friday, July 25th. Stockholders of record on Friday, June 27th will be issued a dividend of $0.32 per share. This represents a $1.28 dividend on an annualized basis and a dividend yield of 0.67%. Danaher's payout ratio is currently 24.85%.

Insiders Place Their Bets

In related news, Chairman Steven M. Rales sold 1,250,000 shares of the company's stock in a transaction on Monday, May 12th. The stock was sold at an average price of $196.74, for a total transaction of $245,925,000.00. Following the completion of the sale, the chairman owned 3,105,808 shares in the company, valued at approximately $611,036,665.92. This represents a 28.70% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, EVP Christopher Paul Riley sold 15,805 shares of the company's stock in a transaction on Wednesday, April 30th. The shares were sold at an average price of $198.00, for a total value of $3,129,390.00. Following the sale, the executive vice president owned 15,179 shares of the company's stock, valued at approximately $3,005,442. This trade represents a 51.01% decrease in their position. The disclosure for this sale can be found here. Corporate insiders own 11.10% of the company's stock.

Analyst Upgrades and Downgrades

Several equities research analysts have recently issued reports on the company. Leerink Partners raised their target price on Danaher from $225.00 to $230.00 and gave the company an "outperform" rating in a research report on Wednesday, April 23rd. Argus decreased their target price on Danaher from $260.00 to $240.00 in a research report on Wednesday, April 23rd. Robert W. Baird lifted their price objective on Danaher from $225.00 to $226.00 and gave the stock an "outperform" rating in a report on Friday. Wells Fargo & Company decreased their price objective on Danaher from $240.00 to $210.00 and set an "equal weight" rating for the company in a report on Wednesday, April 23rd. Finally, TD Cowen lifted their price objective on Danaher from $240.00 to $248.00 and gave the stock a "buy" rating in a report on Wednesday, April 23rd. Three investment analysts have rated the stock with a hold rating and eighteen have given a buy rating to the company. Based on data from MarketBeat, Danaher presently has a consensus rating of "Moderate Buy" and a consensus price target of $248.48.

About Danaher

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.

Want to see what other hedge funds are holding DHR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Danaher Corporation (NYSE:DHR - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.